Search Clinical Trials
585,889 trials
ID
Status
Phase
Title
Sponsor
NCT07601282
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary Incontinence After Pelvic Floor Reconstruction SurgeryShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruiting
NCT07601282Recruiting
—
Development and Validation of a Risk Prediction Model for De Novo Stress Urinary...Shanghai General Hospital...
NCT07601919
Comparison of Interrupted Suturing Versus Continuous Suturing in Laparotomy Wound Closed.Muhammad Aamir LatifCompletedNot Applicable
NCT07601919Completed
Not Applicable
Comparison of Interrupted Suturing Versus Continuous Suturing in Laparotomy Woun...Muhammad Aamir Latif
NCT07600866
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan CohortNucleo Research, Inc.Not Yet Recruiting
NCT07600866Not Yet Recruiting
—
Validation of a Body-Composition Segmentation Software on a Diverse Public CT Sc...Nucleo Research, Inc.
NCT07600788
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.Ausper Biopharma Co., Ltd.Not Yet RecruitingPhase 1
NCT07600788Not Yet Recruiting
Phase 1
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AH...Ausper Biopharma Co., Ltd...
NCT07600814
Pain Induced by m-Cresol as PreservativeMedical University of ViennaNot Yet RecruitingEarly Phase 1
NCT07600814Not Yet Recruiting
Early Phase 1
Pain Induced by m-Cresol as PreservativeMedical University of Vie...
NCT07604909
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyFudan UniversityRecruitingPhase 2
NCT07604909Recruiting
Phase 2
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Thera...Fudan University
NCT07603934
The Effect of Different Intra-canal Medications on Postoperative PainCairo UniversityRecruitingEarly Phase 1
NCT07603934Recruiting
Early Phase 1
The Effect of Different Intra-canal Medications on Postoperative PainCairo University
NCT07602036
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronicNot Yet RecruitingNot Applicable
NCT07602036Not Yet Recruiting
Not Applicable
Type 2 Diabetes and Pregnancy a Single-arm Interventional StudyMedtronic
NCT07601737
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell CarcinomaShanghai General Hospital, Shanghai Jiao Tong University School of MedicineRecruitingPhase 2
NCT07601737Recruiting
Phase 2
Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of L...Shanghai General Hospital...
NCT07600775
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuberculosis Infection (MK-8527-019)Merck Sharp & Dohme LLCNot Yet RecruitingPhase 1
NCT07600775Not Yet Recruiting
Phase 1
A Clinical Trial of MK-8527 and Rifampin in Adult Participants With Latent Tuber...Merck Sharp & Dohme LLC
NCT07602218
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 2National Institute on Drug Abuse (NIDA)Not Yet RecruitingNot Applicable
NCT07602218Not Yet Recruiting
Not Applicable
Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Test...National Institute on Dru...
NCT07604298
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic StrokeNanfang Hospital, Southern Medical UniversityNot Yet Recruiting
NCT07604298Not Yet Recruiting
—
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Tre...Nanfang Hospital, Souther...
NCT07603466
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of BasrahEnrolling By InvitationPhase 4
NCT07603466Enrolling By Invitation
Phase 4
Combination Osilodrostat and Cabergoline in Cushing's DiseaseUniversity of Basrah
NCT07602049
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen UniversityRecruitingPhase 2
NCT07602049Recruiting
Phase 2
Cryoablation Plus Camrelizumab for Advanced Soft Tissue SarcomaSun Yat-sen University
NCT07603232
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anorectal Malformations at the Colorectal Centre of Excellence in QuebecMcGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling By Invitation
NCT07603232Enrolling By Invitation
—
Long-Term Health Outcomes in Children Born With Hirschsprung's Disease and Anore...McGill University Health...
NCT07601490
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyNot Yet RecruitingNot Applicable
NCT07601490Not Yet Recruiting
Not Applicable
The Effect of Nerve Blocks on Analgesia in Breast Cancer SurgerySultan Abdulhamid Han Tra...
NCT07604766
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in ChinaGenmabNot Yet RecruitingPhase 3
NCT07604766Not Yet Recruiting
Phase 3
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Inv...Genmab
NCT07605117
Isoinertial Training in Patients With COPDUniversidad Manuela BeltránNot Yet RecruitingNot Applicable
NCT07605117Not Yet Recruiting
Not Applicable
Isoinertial Training in Patients With COPDUniversidad Manuela Beltr...
NCT07603154
Peng's "Fenjin Tuina" for Superior Cluneal Nerve Entrapment Syndrome: A Prospective, Randomized, Single-center TrialGuangzhou University of Chinese MedicineEnrolling By InvitationNot Applicable
NCT07603154Enrolling By Invitation
Not Applicable
Peng's "Fenjin Tuina" for Superior Cluneal Nerve Entrapment Syndrome: A Prospect...Guangzhou University of C...
Result Breakdown
Not yet recruiting10 (50%)
Recruiting5 (25%)
Enrolling by invitation3 (15%)
Completed2 (10%)
not_applicable7 (35%)
Not Specified4 (20%)
Phase 23 (15%)
Phase 12 (10%)
Early Phase 12 (10%)
Phase 41 (5%)
Phase 31 (5%)